Pfs Investments Inc. Immuno Gen, Inc. Transaction History

Pfs Investments Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $45,530 - $65,754	-10,163 Reduced 27.23%	27,156 $130,000
Q2 2022 Aug 12, 2022	SELL	$3.15 - $5.76 $45,045 - $82,368	-14,300 Reduced 27.7%	37,319 $168,000
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $7,668 - $13,464	-1,800 Reduced 3.37%	51,619 $246,000
Q4 2021 Feb 11, 2022	BUY	$4.75 - $7.5 $2,793 - $4,410	588 Added 1.11%	53,419 $396,000
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $21,038 - $27,618	-4,191 Reduced 7.35%	52,831 $330,000
Q2 2021 Aug 13, 2021	BUY	$5.79 - $8.6 $31,393 - $46,629	5,422 Added 10.51%	57,022 $363,000
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $56,101 - $90,884	8,631 Added 20.09%	51,600 $418,000
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $25,670 - $53,145	6,938 Added 19.26%	42,969 $296,000
Q3 2020 Nov 13, 2020	BUY	$3.45 - $4.89 $16,190 - $22,948	4,693 Added 14.98%	36,031 $130,000
Q2 2020 Aug 14, 2020	BUY	$3.32 - $5.34 $12,330 - $19,832	3,714 Added 13.44%	31,338 $144,000
Q1 2020 May 13, 2020	BUY	$2.12 - $6.8 $14,131 - $45,328	6,666 Added 31.81%	27,624 $94,000
Q4 2019 Feb 12, 2020	BUY	$2.25 - $5.8 $5,784 - $14,911	2,571 Added 13.98%	20,958 $107,000
Q3 2019 Nov 05, 2019	BUY	$2.22 - $3.39 $15,064 - $23,004	6,786 Added 58.49%	18,387 $44,000
Q2 2019 Jul 10, 2019	BUY	$1.8 - $3.3 $20,881 - $38,283	11,601 New	11,601 $28,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Pfs Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Pfs Investments Inc. with notifications on news.